調(diào)肝降壓飲治療高血壓病肝陽上亢證的臨床研究
[Abstract]:Objective: to observe the clinical effect of Tiaogan Jiangya decoction in the treatment of hypertension patients with hyperactivity of liver yang from the method of calming liver latent yang and soothing liver qi. Methods: according to the design method of random and control, 60 patients who met the standard were divided into treatment group (n = 30) and control group (n = 30). The course of treatment was 12 weeks each. The control group was treated with western medicine alone, and the treatment group was treated with Tianggan Jiangya decoction. Result: 1. After treatment, systolic and diastolic blood pressure in the two groups decreased, but the decrease in the treatment group was better than that in the control group, and the total effective rate of blood pressure in the two groups was 86.67% and 66.67%, respectively. the antihypertensive effect of the treatment group was significantly higher than that of the control group. The number of blood pressure reaching the standard and the rate of reaching the standard of blood pressure in the treatment group were significantly better than those in the control group, and the time of reaching the standard of blood pressure in the treatment group was significantly shorter than that in the control group. After treatment, the 24 h ambulatory blood pressure indexes of the two groups were improved to varying degrees, but the treatment group was obviously dominant. 4. After treatment, the comprehensive curative effect of TCM syndrome and the curative effect of single syndrome in the two groups were significantly better than those in the control group. 5. The blood lipid levels of the two groups were compared between the two groups before and after treatment, except for the improvement of TG in the treatment group, there was no significant difference between the two groups. Conclusion: Tiaogan Jiangya decoction has a good antihypertensive effect on patients with hyperactivity of liver yang hypertension, and obviously relieves the related symptoms of the patients. It has the advantages of safety and reliability, and is worthy of clinical application.
【學(xué)位授予單位】:山東中醫(yī)藥大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2016
【分類號】:R259
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 宋立君;盧成志;趙向東;李超;王麗;;經(jīng)皮腎去交感神經(jīng)術(shù)對老年頑固性高血壓患者療效和安全性觀察[J];中外醫(yī)學(xué)研究;2015年07期
2 祁怡馨;謝雁鳴;黎元元;;基于文獻(xiàn)分析的高血壓中醫(yī)證候及證候要素的研究[J];北京中醫(yī)藥大學(xué)學(xué)報(bào);2014年11期
3 王長遠(yuǎn);;β受體阻滯劑與高血壓患者的治療[J];中華高血壓雜志;2014年11期
4 李云;楊鵬;吳壽嶺;武英;趙丹丹;任琦;;高血壓病的三級預(yù)防策略[J];中國預(yù)防醫(yī)學(xué)雜志;2014年04期
5 劉偉霞;賴秀梅;;高血壓的健康管理與健康教育[J];大家健康(學(xué)術(shù)版);2013年23期
6 楊曉紅;李愛民;李文志;;交感神經(jīng)系統(tǒng)與高血壓的研究進(jìn)展[J];心血管病學(xué)進(jìn)展;2013年05期
7 李仁國;;柴胡有效成分及藥理作用分析[J];陜西中醫(yī);2013年06期
8 張藝軍;劉城;吳平生;鐘武裝;;血管緊張素轉(zhuǎn)換酶抑制劑和血管緊張素Ⅱ受體拮抗劑對高血壓患者血管僵硬度作用差異的Meta分析[J];中國全科醫(yī)學(xué);2012年33期
9 劉曉飛;;抗高血壓新藥研究進(jìn)展[J];中國全科醫(yī)學(xué);2012年26期
10 馬愛翠;楊雪;姜瑩;李;;管華詩;劉紅兵;;海洋平肝潛陽中藥石決明對血管緊張素轉(zhuǎn)化酶抑制作用研究[J];中國海洋大學(xué)學(xué)報(bào)(自然科學(xué)版);2012年Z2期
,本文編號:2495152
本文鏈接:http://sikaile.net/zhongyixuelunwen/2495152.html